Diagnostic performance of an optimized transcriptomic signature of risk of tuberculosis in cryopreserved peripheral blood mononuclear cells

Tuberculosis (Edinb). 2018 Jan:108:124-126. doi: 10.1016/j.tube.2017.11.001. Epub 2017 Nov 6.

SATVI Clinical Immunology Team:
Sindile Matiwane, Lungisa Jaxa, Noncedo Xoyana, Constance Schreuder, Janelle Botes, Hadn Africa, Lebohang Makhethe, Marcia Steyn

¹ South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, 7925, Cape Town, South Africa.
² The Center for Infectious Disease Research, Seattle, 98109, WA, USA.
³ South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, 7925, Cape Town, South Africa; Department of Statistical Sciences, University of Cape Town, Cape Town, 7925, South Africa.
⁴ South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, 7925, Cape Town, South Africa. Electronic address: thomas.scriba@uct.ac.za.

No abstract available

Keywords: Biomarker; Correlate of risk; Diagnostic; PBMC; Whole blood; mRNA.

Publication types